Literature DB >> 417929

Enhanced sympathetic nervous activity after intravenous propranolol in ischaemic heart disease: plasma noradrenaline splanchnic blood flow and mixed venous oxygen saturation at rest and during exercise.

J F Hansen, B Hesse, N J Christensen.   

Abstract

To study the mechanisms by which acute beta-adrenergic blockade may change the activity of the sympathetic nervous system we have measured haemodynamic responses including splanchnic blood flow in twenty-three patients with ischaemic heart disease at rest and during supine exercise before and after i.v. injection of 0.039 mmol (10 mg) dl-propranolol. After propranolol both at rest and on exercise blood pressure, cardiac output and heart rate decreased, while splanchnic vascular resistance increased; mixed venous oxygen saturation decreased whilst arterial oxygen saturation and oxygen uptake were unchanged. Plasma noradrenaline increased after propranolol, values correlating with mixed venous oxygen saturation and splanchnic vascular resistance, both at rest and during exercise before and after propranolol, only at rest was there any correlation with arterial blood pressure. The increase in sympathetic nervous activity after propranolol may be due to a reduction in cardiac output and thereby alteration of the metabolic state (oxygen or related factors) in tissues. Afferent neural signals from the tissues may play a significant role in the regulation of sympathetic nervous activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 417929     DOI: 10.1111/j.1365-2362.1978.tb00805.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  16 in total

1.  Ramp work tests with three different beta-blockers in normal human subjects.

Authors:  R L Hughson
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

2.  Effect of labetalol on plasma noradrenaline and adrenaline in hypertensive man.

Authors:  N J Christensen; J Trap-Jensen; T L Svendsen; S Rasmussen; P E Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

Review 3.  Catecholamines and diabetes mellitus.

Authors:  N J Christensen
Journal:  Diabetologia       Date:  1979-04       Impact factor: 10.122

4.  Relationship of plasma catecholamines to blood pressure in hypertensive patients during beta-adrenoceptor blockade with and without intrinsic sympathomimetic activity.

Authors:  R Kirsten; B Heintz; D Böhmer; K Nelson; S Roth; D Welzel
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

5.  Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise.

Authors:  G Planz; R Planz
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

6.  Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.

Authors:  H J Kornerup; E B Pedersen; N J Christensen; A Pedersen; G Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

7.  Lack of adrenergic influence on renin release after furosemide in normal man.

Authors:  J Elmgreen; B Hesse; N J Christensen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 8.  Pharmacokinetic drug interactions with ACE inhibitors.

Authors:  H Shionoiri
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

9.  Unchanged peripheral sympathetic activity following withdrawal of chronic metoprolol treatment. A study of noradrenaline concentrations and kinetics in plasma.

Authors:  G Olsson; M Daleskog; P Hjemdahl; N Rehnqvist
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

Review 10.  Blood hormones as markers of training stress and overtraining.

Authors:  A Urhausen; H Gabriel; W Kindermann
Journal:  Sports Med       Date:  1995-10       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.